| Melanoma predicts response to …PREDICTS_RESPONSE_TO151 of 151show fewer |
|---|
| in context · predicts response to | BRAF V600 → predicts response to Cobimetinib 2 source records aggregated | sensitivity | A | Melanoma | 2 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600 → predicts response to Vemurafenib 2 source records aggregated | sensitivity | A | Melanoma | 2 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600 → predicts response to Atezolizumab | sensitivity | A | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600 → predicts response to Binimetinib | sensitivity | A | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600 → predicts response to Encorafenib | sensitivity | A | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Vemurafenib 7 source records aggregated | sensitivity | B | Melanoma | 7 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600KSNV → predicts response to Trametinib 6 source records aggregated | sensitivity | B | Melanoma | 6 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600KSNV → predicts response to Dabrafenib 6 source records aggregated | sensitivity | B | Melanoma | 6 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Trametinib 6 source records aggregated | sensitivity | B | Melanoma | 6 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Dabrafenib 5 source records aggregated | sensitivity | B | Melanoma | 5 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Dabrafenib 3 source records aggregated | resistance | B | Melanoma | 3 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Vemurafenib 3 source records aggregated | resistance | B | Melanoma | 3 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600KSNV → predicts response to Vemurafenib 3 source records aggregated | sensitivity | B | Melanoma | 3 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600 → predicts response to Trametinib 3 source records aggregated | sensitivity | B | Melanoma | 3 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600 → predicts response to Dabrafenib 3 source records aggregated | sensitivity | B | Melanoma | 3 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600 → predicts response to Cobimetinib 2 source records aggregated | sensitivity | B | Melanoma | 2 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600 → predicts response to Vemurafenib 2 source records aggregated | sensitivity | B | Melanoma | 2 | Curated | civic | graph → |
| in context · predicts response to | PRKDC Mutationother → predicts response to Anti-CTLA-4 Monoclonal Antibody | sensitivity | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | KRAS Mutationother → predicts response to Dabrafenib | resistance | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | KRAS Mutationother → predicts response to Vemurafenib | resistance | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | NRAS Mutationother → predicts response to Dabrafenib | resistance | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | NRAS Mutationother → predicts response to Vemurafenib | resistance | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600KSNV → predicts response to Dabrafenib | resistance | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600KSNV → predicts response to Vemurafenib | resistance | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF Amplificationamplification → predicts response to Dabrafenib | resistance | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF Amplificationamplification → predicts response to Vemurafenib | resistance | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF G469 → predicts response to BRAF Inhibitor | sensitivity | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF G469 → predicts response to Mitogen-Activated Protein Kinase Kinase Inhibitor | sensitivity | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF intron 9 rearrangementstructural → predicts response to Dabrafenib | resistance | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF intron 9 rearrangementstructural → predicts response to Vemurafenib | resistance | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF intron 10 rearrangementstructural → predicts response to Dabrafenib | resistance | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF intron 10 rearrangementstructural → predicts response to Vemurafenib | resistance | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF L505HSNV → predicts response to Vemurafenib | resistance | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT Mutationother → predicts response to Imatinib | sensitivity | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT Exon 11 Mutation → predicts response to Imatinib | sensitivity | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Cobimetinib | sensitivity | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | CD274 Expressionexpression → predicts response to Pembrolizumab | sensitivity | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | CD274 Expressionexpression → predicts response to Nivolumab | sensitivity | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | NRAS Q61SNV → predicts response to Vemurafenib | resistance | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600DSNV → predicts response to Dabrafenib | sensitivity | B | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600DSNV → predicts response to BRAF Inhibitor 2 source records aggregated | sensitivity | C | Melanoma | 2 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600MSNV → predicts response to Dabrafenib | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Dabrafenib | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | NRAS Q61RSNV → predicts response to Belvarafenib | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | NRAS G12ASNV → predicts response to Belvarafenib | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PREX2 R172ISNV → predicts response to Vemurafenib | resistance | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600KSNV → predicts response to Vemurafenib | resistance | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600 → predicts response to Refametinib | resistance | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Pictilisib | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF Fusionfusion → predicts response to Sorafenib | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | NRAS Q61RSNV → predicts response to Temozolomide | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | NRAS Q61LSNV → predicts response to Temozolomide | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | NRAS G13DSNV → predicts response to Tanespimycin | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF Fusionfusion → predicts response to Belvarafenib | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | RAF1 Fusionfusion → predicts response to Binimetinib | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK3 Fusionfusion → predicts response to Entrectinib | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600_K601>E → predicts response to Mitogen-Activated Protein Kinase Kinase Inhibitor | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600_K601>E → predicts response to BRAF Inhibitor | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600DSNV → predicts response to Mitogen-Activated Protein Kinase Kinase Inhibitor | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | JAK2 Splice Site (c.1641+2T>G)splice → predicts response to Pembrolizumab | resistance | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT D820YSNV → predicts response to Imatinib | resistance | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF Fusionfusion → predicts response to Trametinib | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600KSNV → predicts response to Vemurafenib | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT Exon 11 Mutation → predicts response to Sunitinib | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | ROS1 Fusionfusion → predicts response to Entrectinib | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | RAF1 Fusionfusion → predicts response to Trametinib | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF Amplificationamplification → predicts response to Dabrafenib | resistance | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF Amplificationamplification → predicts response to Trametinib | resistance | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600 → predicts response to Dabrafenib | resistance | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600 → predicts response to Trametinib | resistance | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | AKT1 Q79KSNV → predicts response to Dabrafenib | resistance | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | MAP2K1 C121SSNV → predicts response to Vemurafenib | resistance | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF L597RSNV → predicts response to Vemurafenib | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | RAF1 Fusionfusion → predicts response to Cobimetinib | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | RAF1 Fusionfusion → predicts response to Trametinib | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT K642ESNV → predicts response to Dasatinib | sensitivity | C | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Vemurafenib 4 source records aggregated | resistance | D | Melanoma | 4 | Curated | civic | graph → |
| in context · predicts response to | AKT1 Q79KSNV → predicts response to Vemurafenib 2 source records aggregated | resistance | D | Melanoma | 2 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Uprosertib 2 source records aggregated | sensitivity | D | Melanoma | 2 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600DSNV → predicts response to Vemurafenib 2 source records aggregated | sensitivity | D | Melanoma | 2 | Curated | civic | graph → |
| in context · predicts response to | AKT1 E17KSNV → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | IFNGR1 Lossdeletion_cna → predicts response to Ipilimumab | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | KRAS Amplificationamplification → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA Overexpressionexpression → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | AKT3 Overexpressionexpression → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA D350GSNV → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | KRAS G12DSNV → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA E545GSNV → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA E545KSNV → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT D820YSNV → predicts response to Sunitinib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | TBK1 Overexpressionexpression → predicts response to AZ909 | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | TBK1 Overexpressionexpression → predicts response to Selumetinib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Selumetinib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Dactolisib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF Fusionfusion → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Lossdeletion_cna → predicts response to Uprosertib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | AKT1 E17KSNV → predicts response to Uprosertib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | MAP2K2 N126DSNV → predicts response to Dabrafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | MAP2K2 N126DSNV → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | MAP2K2 L46FSNV → predicts response to Dabrafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | MAP2K2 L46FSNV → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | NRAS Gain → predicts response to Binimetinib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3R2 N561DSNV → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | AKT3 E17KSNV → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | MERTK OVEREXPRESSIONexpression → predicts response to UNC1062 | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PDGFRA G853DSNV → predicts response to Imatinib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PDGFRA G853DSNV → predicts response to Crenolanib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PDGFRA H845YSNV → predicts response to Imatinib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PDGFRA H845YSNV → predicts response to Crenolanib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PDGFRA R841KSNV → predicts response to Imatinib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PDGFRA R841KSNV → predicts response to Crenolanib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PDGFRA P577SSNV → predicts response to Imatinib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PDGFRA P577SSNV → predicts response to Crenolanib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | NRAS Mutationother → predicts response to Binimetinib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF Fusionfusion → predicts response to Trametinib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF Fusionfusion → predicts response to Trametinib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF Fusionfusion → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | MTOR P2213SSNV → predicts response to PI3K/BET Inhibitor LY294002 | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | MTOR P2213SSNV → predicts response to Capivasertib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | MTOR H1968YSNV → predicts response to Capivasertib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | MTOR H1968YSNV → predicts response to PI3K/BET Inhibitor LY294002 | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | ATM Mutationother → predicts response to Temozolomide | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Nutlin-3 | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to PLX4720 | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | NF1 Lossdeletion_cna → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT L576PSNV → predicts response to Dasatinib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT L576PSNV → predicts response to Sorafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT L576PSNV → predicts response to Imatinib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT L576PSNV → predicts response to Nilotinib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | MAP2K1 Q56PSNV → predicts response to Selumetinib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | MAP2K1 P124SSNV → predicts response to Selumetinib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | MAP2K2 C125SSNV → predicts response to Dabrafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | MAP2K2 C125SSNV → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to JQEZ5 | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | EZH2 Y646FSNV → predicts response to JQEZ5 | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Underexpressionexpression → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600 → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | CTNNB1 Activating Mutation → predicts response to Anti-CTLA-4 Monoclonal Antibody | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | CTNNB1 Activating Mutation → predicts response to Anti-PD-L1 Monoclonal Antibody | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | SOX10 Lossdeletion_cna → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF L505HSNV → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | STAG3 Underexpressionexpression → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | STAG2 Underexpressionexpression → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | NRAS Mutationother → predicts response to Trametinib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | NRAS Mutationother → predicts response to Omipalisib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | RAC1 P29SSNV → predicts response to Dabrafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | RAC1 P29SSNV → predicts response to Vemurafenib | resistance | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB4 Mutationother → predicts response to Lapatinib | sensitivity | D | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 Fusionfusion → predicts response to Larotrectinib | sensitivity | E | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 Fusionfusion → predicts response to Larotrectinib | sensitivity | E | Melanoma | 1 | Curated | civic | graph → |
| in context · predicts response to | NTRK1 Fusionfusion → predicts response to Larotrectinib | sensitivity | E | Melanoma | 1 | Curated | civic | graph → |